AzTrials
AzTrials

StrokeNCT04092322

Validation of Physical Activity Scale for the Elderly (PASE) in Stroke Patients

An observational study of Stroke, run by Marmara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Physical Activity Scale for the Elderly (PASE) is a self-report questionnaire on exercise, home, and work-related physical activities performed during the last week. PASE has shown to be reliable and valid in different populations of people between 65 and 100 years of age and after stroke. Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
Stroke
What is being tested?
Actical accelerometers (Philips Respironics) and PASE
Type of treatment
Medical device
How many people
25 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Sep 2019to 25 Nov 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with stroke between the ages of 40-80 who can walk independently or with an assistive device

Who may be able to join

  • Patients with first ever, unilateral stroke
  • Patients with stroke who can walk independently or with an assistive device
  • Being at between the ages of 40-80

Who cannot join

  • Illiteracy
  • Having severely impaired mental function and being unable to complete questionnaires
  • Presence of neglect, demantia, apraxia
  • Having uncontrolled hypertension, cardiopulmonary disease

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Esra Giray

    Istanbul, 34899

Other trials in Turkey (Türkiye)

About this study

Official title: Validation of Physical Activity Scale for the Elderly (PASE) in Stroke Patients: Relationship Between PASE and Physical Activity Measured by Portable Accelerometer

The Physical Activity Scale for the Elderly (PASE) is a self-report questionnaire on exercise, home, and work-related physical activities performed during the last week. PASE has shown to be reliable and valid in different populations of people between 65 and 100 years of age and after stroke. However, its validation on stroke was based on another self report questionnaire that assess physical activity called ''Senior Fitness Test''. Since accelerometers are more objective methods to assess PA, to the best of our knowledge, self-report physical activity questionnaires should be validated based on accelerometer derived physical activity data. The aim of this study is to validate PASE in patients with stroke based on accelerometer data.

Read the detailed description

The Physical Activity Scale for the Elderly (PASE) is a self-report questionnaire on exercise, home, and work-related physical activities performed during the last week. PASE has shown to be reliable and valid in different populations of people between 65 and 100 years of age and after stroke. However, its validation on stroke was based on another self report questionnaire that assess physical activity (PA) called ''Senior Fitness Test''. There are four methods to measure physical activity: 1. Self-Report Questionnaires 2.Self-Report Activity Diaries/Logs 3.Direct Observation 4. Devices (Accelerometers, pedometers, arm band, Heart-Rate Monitors). Accelerometers can measure PA accurately and have ability capture large amounts of data. Accelerometers measure acceleration (activity counts:AC) in real time and detect movement in up to three orthogonal planes (anteroposterior, mediolateral, and vertical) These counts are then translated into a metric of interest, which can be biological (e.g. energy expenditure) or PA patterns (e.g. stationary). There are pros and cons of measurement methods of physical activity. Strengths of accelerometers include minute-by-minute on-line monitoring, capturing intensity level. Accumulated AC provide an accurate estimate of the duration and intensity of body movement at the waist and were summed across the whole day to assess total PA volume. However, accelerometers are expensive and require technical expertise, specialized hardware, software, and individual programming. Self-report PA measurement methods are able to measure large numbers of participants at low cost. Since accelerometers are more objective methods to assess PA, to the best of our knowledge, self-report physical activity questionnaires should be validated based on accelerometer derived physical activity data. The aim of this study is to validate PASE in patients with stroke based on accelerometer data.

Conditions
Stroke
Being tested
Actical accelerometers (Philips Respironics), PASE
Keywords
stroke, physical activity, accelerometer, physical activity scale for elderly
Medical subject headings
Stroke, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Actical accelerometers (Philips Respironics)Device

    patients with stroke will be evaluated by using PASE scale and accelerometer results (accelerometer will be held from Monday to Friday

  • PASEOther

    Physical Activity Scale for Elderly

Study groups in NCT04092322
Study groupRoleWhat they receive
Patients with subacute chronic strokePatients with subacute chronic stroke between the ages of 40-80
Receives: Device: Actical accelerometers (Philips Respironics); Other: PASE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PASE

    Physical Activity Score for Elderly

    Measured: Day 0

Secondary outcomes (12)
  1. ACtotal

    Total activity count obtained from accelerometer

    Measured: Day 0

  2. EE total

    Total energy expenditure obtained from accelerometer

    Measured: Day 0

  3. AC moderate

    activity counts derived from accelerometer during moderate physical activity

    Measured: Day 0

  4. EE moderate

    energy expenditure obtained from accelerometer during moderate physical activity

    Measured: Day 0

  5. AC light

    activity counts derived from accelerometer during light physical activity

    Measured: Day 0

  6. EE light

    energy expenditure obtained from accelerometer during light physical activity

    Measured: Day 0

  7. AC vigorous

    activity counts derived from accelerometer during vigorous physical activity

    Measured: Day 0

  8. EE vigorous

    energy expenditure obtained from accelerometer during vigorous physical activity

    Measured: Day 0

  9. AC sedentary

    activity counts derived from accelerometer during sedentary physical activity

    Measured: Day 0

  10. EE sedentary

    energy expenditure obtained from accelerometer during sedentary physical activity

    Measured: Day 0

  11. step count

    total step count obtained from accelerometer

    Measured: Day 0

  12. Stroke Impact Scale total score

    Stroke Impact Scale is a stroke specific quality of life scale. The current version of the SIS (SIS version 3.0) is a 59-item patient-reported outcome measure, covering 8 domains: strength (4 items), hand function (5 items), mobility (9 items), activities of daily living (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items). Domains are scored on a metric of 0 to 100, with higher scores indicating better self-reported health. Four of the scales of the SIS can be combined into a composite physical domain (strength, hand function, physical and instrumental activities of daily living, and mobility), with scores also presented on a 0 to 100 metric.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2019
  2. Study start25 Sep 2019
  3. Primary completion25 Nov 2019
  4. Study completion25 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04092322
Sponsor's protocol ID
09.2019.205
Status last verified
Sep 2019
First submitted
15 Sep 2019
Last updated
26 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Marianne Lindahl, Lotte Hansen, Anders Pedersen, Thomas Truelsen & Gudrun Boysen (2008) Self-reported physical activity after ischemic stroke correlates with physical capacity, Advances in Physiotherapy, 10:4, 188-194, DOI: 10.1080/14038190802490025

  • Hills AP, Mokhtar N, Byrne NM. Assessment of physical activity and energy expenditure: an overview of objective measures. Front Nutr. 2014 Jun 16;1:5. doi: 10.3389/fnut.2014.00005. eCollection 2014.

    PubMed 25988109
  • Persson CU, Hansson PO, Lappas G, Danielsson A. Physical Activity Levels and Their Associations With Postural Control in the First Year After Stroke. Phys Ther. 2016 Sep;96(9):1389-96. doi: 10.2522/ptj.20150367. Epub 2016 Mar 24.

    PubMed 27013578
  • Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. Practical guide to measuring physical activity. J Acad Nutr Diet. 2014 Feb;114(2):199-208. doi: 10.1016/j.jand.2013.09.018. Epub 2013 Nov 28. No abstract available.

    PubMed 24290836

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PASE (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04092322, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04092322 | AzTrials